Home LiteratureArticle Details
PMID: 10490608 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Roles of cell division and gene transcription in the methylation of CpG islands.

Molecular and cellular biology ·Vol. 19 ·No. 10 ·1999-10-00 ·Pages 6690-8

Bender CM, Gonzalgo ML, Gonzales FA, Nguyen CT, Robertson KD, Jones PA

Abstract

De novo methylation of CpG islands within the promoters of eukaryotic genes is often associated with their transcriptional repression, yet the methylation of CpG islands located downstream of promoters does not block transcription. We investigated the kinetics of mRNA induction, demethylation, and remethylation of the p16 promoter and second-exon CpG islands in T24 cells after 5-aza-2'-deoxycytidine (5-Aza-CdR) treatment to explore the relationship between CpG island methylation and gene transcription. The rates of remethylation of both CpG islands were associated with time but not with the rate of cell division, and remethylation of the p16 exon 2 CpG island occurred at a higher rate than that of the p16 promoter. We also examined the relationship between the remethylation of coding sequence CpG islands and gene transcription. The kinetics of remethylation of the p16 exon 2, PAX-6 exon 5, c-ABL exon 11, and MYF-3 exon 3 loci were examined following 5-Aza-CdR treatment because these genes contain exonic CpG islands which are hypermethylated in T24 cells. Remethylation occurred most rapidly in the p16, PAX-6, and c-ABL genes, shown to be transcribed prior to drug treatment. These regions also exhibited higher levels of remethylation in single-cell clones and subclones derived from 5-Aza-CdR-treated T24 cells. Our data suggest that de novo methylation is not restricted to the S phase of the cell cycle and that transcription through CpG islands does not inhibit their remethylation.

MeSH Terms
Azacitidine/analogs & derivatives,pharmacology Cell Division CpG Islands Cyclin-Dependent Kinase Inhibitor p16/genetics DNA Methylation/drug effects DNA-Binding Proteins/genetics Decitabine Exons Eye Proteins Gene Expression Regulation Homeodomain Proteins Models, Genetic MyoD Protein/genetics PAX6 Transcription Factor Paired Box Transcription Factors Promoter Regions, Genetic Proto-Oncogene Proteins c-abl/genetics Repressor Proteins Transcription, Genetic Tumor Cells, Cultured
Chemicals
Cyclin-Dependent Kinase Inhibitor p16 DNA-Binding Proteins Eye Proteins Homeodomain Proteins MyoD Protein MyoD1 myogenic differentiation protein PAX6 Transcription Factor Paired Box Transcription Factors Repressor Proteins Decitabine Proto-Oncogene Proteins c-abl Azacitidine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Bender C M
Urologic Research Laboratory, USC/Norris Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles, California 90089-9181, USA.
Gonzalgo M L
Gonzales F A
Nguyen C T
Robertson K D
Jones P A
References (51)
51 references, click to expand
  1. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.
    Nat Genet. 1998 Jun;19(2):187-91 PMID: 9620779
  2. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines.
    Cell. 1990 Aug 10;62(3):503-14 PMID: 1974172
  3. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases.
    Nat Genet. 1998 Jul;19(3):219-20 PMID: 9662389
  4. An alternative promoter in the mouse major histocompatibility complex class II I-Abeta gene: implications for the origin of CpG islands.
    Mol Cell Biol. 1998 Aug;18(8):4433-43 PMID: 9671453
  5. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
    Genomics. 1998 Nov 1;53(3):260-8 PMID: 9799591
  6. Cancer epigenetics comes of age.
    Nat Genet. 1999 Feb;21(2):163-7 PMID: 9988266
  7. The DNA methylation paradox.
    Trends Genet. 1999 Jan;15(1):34-7 PMID: 10087932
  8. CpG islands as gene markers in the human genome.
    Genomics. 1992 Aug;13(4):1095-107 PMID: 1505946
  9. Parental-origin-specific epigenetic modification of the mouse H19 gene.
    Nature. 1993 Apr 22;362(6422):751-5 PMID: 8469285
  10. Effects of DNA methylation on DNA-binding proteins and gene expression.
    Curr Opin Genet Dev. 1993 Apr;3(2):226-31 PMID: 8504247
  11. Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching.
    Am J Hum Genet. 1993 Jul;53(1):113-24 PMID: 8391213
  12. Inactive chromatin spreads from a focus of methylation.
    Mol Cell Biol. 1993 Dec;13(12):7372-9 PMID: 7504173
  13. Role for DNA methylation in genomic imprinting.
    Nature. 1993 Nov 25;366(6453):362-5 PMID: 8247133
  14. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.
    Cancer Res. 1994 May 15;54(10):2552-5 PMID: 8168078
  15. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer.
    Mol Cell Biol. 1994 Jun;14(6):4225-32 PMID: 8196660
  16. Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment.
    Nature. 1977 May 26;267(5609):364-6 PMID: 68440
  17. Cellular differentiation, cytidine analogs and DNA methylation.
    Cell. 1980 May;20(1):85-93 PMID: 6156004
  18. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation.
    Science. 1981 Jan 23;211(4480):393-6 PMID: 6164095
  19. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.
    Am J Hum Genet. 1991 May;48(5):880-8 PMID: 1673287
  20. Growth regulation of mouse DNA methyltransferase gene expression.
    J Biol Chem. 1991 Jun 5;266(16):10027-30 PMID: 2037559
  21. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.
    Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1827-31 PMID: 1542678
  22. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.
    Cell. 1992 Jun 12;69(6):915-26 PMID: 1606615
  23. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Cancer Res. 1995 Oct 15;55(20):4531-5 PMID: 7553622
  24. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.
    Nat Med. 1995 Jul;1(7):686-92 PMID: 7585152
  25. DNA methylation errors and cancer.
    Cancer Res. 1996 Jun 1;56(11):2463-7 PMID: 8653676
  26. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Cancer Res. 1996 Feb 15;56(4):722-7 PMID: 8631003
  27. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11757-62 PMID: 8876210
  28. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE).
    Nucleic Acids Res. 1997 Jun 15;25(12):2529-31 PMID: 9171109
  29. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation.
    J Biol Chem. 1997 Aug 29;272(35):22322-9 PMID: 9268383
  30. Stability of patch methylation and its impact in regions of transcriptional initiation and elongation.
    Mol Cell Biol. 1997 Oct;17(10):5897-904 PMID: 9315647
  31. Imprinted expression of the Igf2r gene depends on an intronic CpG island.
    Nature. 1997 Oct 16;389(6652):745-9 PMID: 9338788
  32. Alterations in DNA methylation: a fundamental aspect of neoplasia.
    Adv Cancer Res. 1998;72:141-96 PMID: 9338076
  33. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Cancer Res. 1998 Jan 1;58(1):95-101 PMID: 9426064
  34. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines.
    Cancer Res. 1998 Mar 15;58(6):1245-52 PMID: 9515812
  35. DNA methylation as a target for drug design.
    Pharm Res. 1998 Feb;15(2):175-87 PMID: 9523301
  36. Dependence of transcriptional repression on CpG methylation density.
    Mol Cell Biol. 1994 Aug;14(8):5487-94 PMID: 7518564
  37. High sensitivity mapping of methylated cytosines.
    Nucleic Acids Res. 1994 Aug 11;22(15):2990-7 PMID: 8065911
  38. Sp1 elements protect a CpG island from de novo methylation.
    Nature. 1994 Sep 29;371(6496):435-8 PMID: 8090226
  39. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
    Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9700-4 PMID: 7937876
  40. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
    Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10722-6 PMID: 7938018
  41. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island.
    Genes Dev. 1994 Oct 1;8(19):2282-92 PMID: 7958895
  42. A novel p16INK4A transcript.
    Cancer Res. 1995 Jul 15;55(14):2995-7 PMID: 7541708
  43. X-chromosome inactivation and cell memory.
    Trends Genet. 1992 May;8(5):169-74 PMID: 1369742
  44. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
    Cancer Res. 1995 Oct 15;55(20):4525-30 PMID: 7553621
  45. Hemimethylated duplex DNAs prepared from 5-azacytidine-treated cells.
    Nucleic Acids Res. 1981 Jun 25;9(12):2933-47 PMID: 6169003
  46. Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA.
    J Mol Biol. 1982 Dec 15;162(3):679-92 PMID: 6187927
  47. Effect of DNA methylation on gene expression.
    Cold Spring Harb Symp Quant Biol. 1983;47 Pt 2:605-9 PMID: 6574866
  48. Methylation of the mouse hprt gene differs on the active and inactive X chromosomes.
    Mol Cell Biol. 1986 Mar;6(3):914-24 PMID: 3022138
  49. CpG islands in vertebrate genomes.
    J Mol Biol. 1987 Jul 20;196(2):261-82 PMID: 3656447
  50. Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance.
    Mol Cell Biol. 1987 Sep;7(9):3076-83 PMID: 2444874
  51. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
    Nature. 1998 May 28;393(6683):386-9 PMID: 9620804
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1999-10-00
Pages
6690-8
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC84656
Subset
IM
Grants
NCI NIH HHS · R37 CA49758 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]